GLUE Monte Rosa Therapeutics, Inc.
Nasdaq · SEC CIK 1826457 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $4.11M 30 sales by 7 insiders
- Filings on record
- 107 since 2022-03-02, latest 2026-07-17 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Janku Filip | Chief Medical Off | — | $1.38M |
| Warmuth Markus | Pres, CEO, Dir | — | $951.1K |
| Dunn Edmund | Principal Accounting Off | — | $483.1K |
| Townson Sharon | CSO | — | $423.9K |
| Manning Anthony M. | Dir | — | $411.2K |
| Champoux Jennifer | COO | — | $311.3K |
| Nickson Philip | Chief Business, Legal Off | — | $151.3K |
| Bowen Matthew | Principal Accounting Off | — | — |
| Behbahani Ali | Dir | — | — |
Transactions 67
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-17 16:05 | 2026-07-16 | GLUE | Warmuth Markus | Pres, CEO, Dir | S - Sale | $23.18 | -9,500 | 585.0K | -2% | -$220.2K | |
| DT | 2026-07-16 16:10 | 2026-07-15 | GLUE | Champoux Jennifer | COO | M - OptEx | $3.98 | +4,351 | 66.7K | +7% | +$17.3K |
| DT | 2026-07-16 16:10 | 2026-07-15 | GLUE | Champoux Jennifer | COO | S - Sale+OE | $23.38 | -4,351 | 62.4K | -7% | -$101.7K |
| DT | 2026-07-07 16:41 | 2026-07-06 | GLUE | Townson Sharon | CSO | M - OptEx | $6.14 | +6,000 | 73.8K | +9% | +$36.8K |
| DMT | 2026-07-07 16:41 | 2026-07-06 | GLUE | Townson Sharon | CSO | S - Sale+OE | $23.31 | -6,000 | 67.8K | -8% | -$139.8K |
| MI | 2026-07-06 17:57 | 2026-07-01 | GLUE | Behbahani Ali | Dir | J - Other | $0.00 | -1.00M | 0 | -100% | $0 |
| DT | 2026-07-01 16:57 | 2026-06-30 | GLUE | Janku Filip | Chief Medical Off | M - OptEx | $13.41 | +5,407 | 66.0K | +9% | +$72.5K |
| DT | 2026-07-01 16:57 | 2026-06-30 | GLUE | Janku Filip | Chief Medical Off | S - Sale+OE | $24.50 | -5,407 | 60.6K | -8% | -$132.5K |
| DT | 2026-06-30 16:05 | 2026-06-29 | GLUE | Janku Filip | Chief Medical Off | M - OptEx | $7.56 | +6,000 | 66.0K | +10% | +$45.4K |
| DT | 2026-06-30 16:05 | 2026-06-29 | GLUE | Janku Filip | Chief Medical Off | S - Sale+OE | $22.95 | -6,000 | 60.0K | -9% | -$137.7K |
| D | 2026-06-30 16:05 | 2026-06-29 | GLUE | Manning Anthony M. | Dir | M - OptEx | $4.16 | +10.0K | 10.0K | New | +$41.6K |
| D | 2026-06-30 16:05 | 2026-06-29 | GLUE | Manning Anthony M. | Dir | S - Sale+OE | $23.11 | -10.0K | 0 | -100% | -$231.1K |
| DMT | 2026-06-25 16:05 | 2026-06-23+ | GLUE | Janku Filip | Chief Medical Off | M - OptEx | $7.56 | +36.0K | 90.0K | +67% | +$272.2K |
| DMT | 2026-06-25 16:05 | 2026-06-23+ | GLUE | Janku Filip | Chief Medical Off | S - Sale+OE | $21.08 | -41.8K | 60.0K | -41% | -$882.2K |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Champoux Jennifer | COO | M - OptEx | $3.98 | +2,175 | 64.5K | +3% | +$8,656 |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Champoux Jennifer | COO | S - Sale+OE | $20.00 | -2,175 | 62.4K | -3% | -$43.5K |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Townson Sharon | CSO | M - OptEx | $6.14 | +3,000 | 70.8K | +4% | +$18.4K |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Townson Sharon | CSO | S - Sale+OE | $20.00 | -3,000 | 67.8K | -4% | -$60.0K |
| DT | 2026-06-18 16:05 | 2026-06-17 | GLUE | Champoux Jennifer | COO | M - OptEx | $3.98 | +2,176 | 64.5K | +3% | +$8,660 |
| DT | 2026-06-18 16:05 | 2026-06-17 | GLUE | Champoux Jennifer | COO | S - Sale+OE | $19.00 | -2,176 | 62.4K | -3% | -$41.3K |
| DT | 2026-06-18 16:05 | 2026-06-17 | GLUE | Townson Sharon | CSO | M - OptEx | $6.14 | +3,000 | 70.8K | +4% | +$18.4K |
| DT | 2026-06-18 16:05 | 2026-06-17 | GLUE | Townson Sharon | CSO | S - Sale+OE | $19.00 | -3,000 | 67.8K | -4% | -$57.0K |
| MT | 2026-06-02 16:05 | 2026-06-01 | GLUE | Warmuth Markus | Pres, CEO, Dir | S - Sale | $19.44 | -5,466 | 594.5K | -0.9% | -$106.3K |
| DT | 2026-06-01 16:05 | 2026-05-29 | GLUE | Townson Sharon | CSO | M - OptEx | $6.14 | +6,000 | 73.8K | +9% | +$36.8K |
| DT | 2026-06-01 16:05 | 2026-05-29 | GLUE | Townson Sharon | CSO | S - Sale+OE | $19.87 | -6,000 | 67.8K | -8% | -$119.2K |
| DT | 2026-05-28 19:10 | 2026-05-27 | GLUE | Champoux Jennifer | COO | M - OptEx | $3.98 | +2,175 | 64.5K | +3% | +$8,656 |
| DT | 2026-05-28 19:10 | 2026-05-27 | GLUE | Champoux Jennifer | COO | S - Sale+OE | $20.00 | -2,175 | 62.4K | -3% | -$43.5K |
| DT | 2026-05-26 16:05 | 2026-05-22 | GLUE | Champoux Jennifer | COO | M - OptEx | $3.98 | +2,176 | 64.5K | +3% | +$8,660 |
| DT | 2026-05-26 16:05 | 2026-05-22 | GLUE | Champoux Jennifer | COO | S - Sale+OE | $19.00 | -2,176 | 62.4K | -3% | -$41.3K |
| D | 2026-05-22 16:05 | 2026-05-21 | GLUE | Manning Anthony M. | Dir | M - OptEx | $4.16 | +10.0K | 10.0K | New | +$41.6K |
| D | 2026-05-22 16:05 | 2026-05-21 | GLUE | Manning Anthony M. | Dir | S - Sale+OE | $18.01 | -10.0K | 0 | -100% | -$180.1K |
| T | 2026-05-05 16:05 | 2026-05-01 | GLUE | Warmuth Markus | Pres, CEO, Dir | S - Sale | $18.92 | -5,467 | 600.0K | -0.9% | -$103.4K |
| 2026-04-15 16:05 | 2026-04-14 | GLUE | Warmuth Markus | Pres, CEO, Dir | S - Sale | $17.64 | -8,000 | 605.5K | -1% | -$141.1K | |
| 2026-04-10 16:07 | 2026-04-09 | GLUE | Nickson Philip | Chief Business, Legal Off | S - Sale | $17.69 | -5,845 | 55.0K | -10% | -$103.4K | |
| D | 2026-04-07 16:10 | 2026-04-06 | GLUE | Bowen Matthew | Principal Accounting Off | A - Grant | — | +4,300 | 25.9K | +20% | — |
| 2026-03-05 | 2026-03-04 | GLUE | Dunn Edmund | Principal Accounting Off | S - Sale | $17.96 | -139 | 22.6K | -0.6% | -$2,496 | |
| T | 2026-03-04 | 2026-03-02 | GLUE | Warmuth Markus | Pres, CEO, Dir | S - Sale | $17.92 | -5,466 | 613.5K | -0.9% | -$98.0K |
| DM | 2026-03-02 | 2026-02-27+ | GLUE | Dunn Edmund | Principal Accounting Off | S - Sale+OE | $18.09 | -25.7K | 22.7K | -53% | -$464.8K |
| DM | 2026-03-02 | 2026-02-27+ | GLUE | Dunn Edmund | Principal Accounting Off | M - OptEx | $13.41 | +25.7K | 47.9K | +116% | +$344.6K |
| 2026-02-24 | 2026-02-23 | GLUE | Janku Filip | Chief Medical Off | S - Sale | $19.50 | -9,189 | 65.8K | -12% | -$179.2K | |
| MT | 2026-01-09 | 2026-01-07 | GLUE | Warmuth Markus | Pres, CEO, Dir | S - Sale | $23.48 | -5,466 | 620.7K | -0.9% | -$128.4K |
| D | 2026-01-05 | 2026-01-05 | GLUE | Champoux Jennifer | COO | S - Sale | $15.17 | -2,629 | 62.4K | -4% | -$39.9K |
| D | 2026-01-05 | 2026-01-02 | GLUE | Champoux Jennifer | COO | A - Grant | — | +35.0K | 65.0K | +117% | — |
| D | 2026-01-05 | 2026-01-05 | GLUE | Nickson Philip | Chief Business, Legal Off | S - Sale | $15.17 | -3,155 | 60.8K | -5% | -$47.9K |
| D | 2026-01-05 | 2026-01-02 | GLUE | Nickson Philip | Chief Business, Legal Off | A - Grant | — | +28.0K | 64.0K | +78% | — |
| D | 2026-01-05 | 2026-01-02 | GLUE | Townson Sharon | CSO | A - Grant | — | +35.0K | 71.0K | +97% | — |
| D | 2026-01-05 | 2026-01-05 | GLUE | Townson Sharon | CSO | S - Sale | $15.17 | -3,155 | 67.8K | -4% | -$47.9K |
| D | 2026-01-05 | 2026-01-05 | GLUE | Warmuth Markus | Pres, CEO, Dir | S - Sale | $15.17 | -10.1K | 624.4K | -2% | -$153.7K |
| D | 2026-01-05 | 2026-01-02 | GLUE | Warmuth Markus | Pres, CEO, Dir | A - Grant | — | +90.0K | 634.5K | +17% | — |
| D | 2026-01-05 | 2026-01-05 | GLUE | Janku Filip | Chief Medical Off | S - Sale | $15.17 | -3,155 | 75.0K | -4% | -$47.9K |
| D | 2026-01-05 | 2026-01-02 | GLUE | Janku Filip | Chief Medical Off | A - Grant | — | +31.0K | 78.2K | +66% | — |
| 2026-01-05 | 2026-01-05 | GLUE | Dunn Edmund | Principal Accounting Off | S - Sale | $15.17 | -1,039 | 22.7K | -4% | -$15.8K | |
| 2025-06-04 | 2025-06-03 | GLUE | Dunn Edmund | Principal Accounting Off | S - Sale | $4.45 | -2,062 | 23.7K | -8% | -$9,176 | |
| 2025-03-25 | 2025-03-24 | GLUE | Leo Chandra P. | Dir | P - Purchase | $5.84 | +10.0K | 10.0K | New | +$58.4K | |
| D | 2025-01-06 | 2025-01-02 | GLUE | Champoux Jennifer | COO | A - Grant | — | +30.0K | 30.0K | New | — |
| D | 2025-01-06 | 2025-01-02 | GLUE | Nickson Philip | Chief Business, Legal Off | A - Grant | — | +36.0K | 36.0K | New | — |
| D | 2025-01-06 | 2025-01-02 | GLUE | Townson Sharon | CSO | A - Grant | — | +36.0K | 36.0K | New | — |
| D | 2025-01-06 | 2025-01-02 | GLUE | Dunn Edmund | Principal Accounting Off | A - Grant | — | +11.8K | 25.8K | +85% | — |
| D | 2025-01-06 | 2025-01-02 | GLUE | Warmuth Markus | Pres, CEO, Dir | A - Grant | — | +128.0K | 544.5K | +31% | — |
| D | 2025-01-06 | 2025-01-02 | GLUE | Janku Filip | Chief Medical Off | A - Grant | — | +36.0K | 45.2K | +392% | — |
| MI | 2024-10-30 | 2024-10-28+ | GLUE | Versant Venture Capital VI, L.P. | 10% | S - Sale | $9.44 | -157.9K | 1.59M | -9% | -$1.49M |
| 2024-10-30 | 2024-10-28 | GLUE | Versant Venture Capital VI, L.P. | 10% | J - Other | $0.00 | -1.02M | 4.08M | -20% | $0 | |
| MI | 2024-10-30 | 2024-10-28 | GLUE | Versant Venture Capital VI, L.P. | 10% | J - Other | $0.00 | -366.6K | 1.64M | -18% | $0 |
| 2024-09-24 | 2024-09-20 | GLUE | Versant Venture Capital VI, L.P. | 10% | S - Sale | $6.53 | -1.13M | 5.10M | -18% | -$7.40M | |
| M | 2024-09-13 | 2024-09-11+ | GLUE | Versant Ventures VI GP, L.P. | 10% | S - Sale | $6.00 | -567.2K | 6.24M | -8% | -$3.40M |
| 2024-07-09 | 2024-07-05 | GLUE | Dunn Edmund | Principal Accounting Off | S - Sale | $3.83 | -1,610 | 13.9K | -10% | -$6,166 | |
| 2024-06-05 | 2024-06-03 | GLUE | Dunn Edmund | Principal Accounting Off | S - Sale | $4.04 | -1,207 | 15.6K | -7% | -$4,876 |
Purchase Sale Sale after option exercise All abbreviations